159 related articles for article (PubMed ID: 38426107)
1. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
2. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
3. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
4. Tubular decoy receptor 2 as a predictor of prognosis in patients with immunoglobulin A nephropathy.
Dai H; Hu W; Lin L; Wang L; Chen J; He Y
Clin Kidney J; 2021 May; 14(5):1458-1468. PubMed ID: 33959273
[TBL] [Abstract][Full Text] [Related]
5. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
[TBL] [Abstract][Full Text] [Related]
7. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
8. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
9. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
Guan J; Wang M; Zhao M; Ni W; Zhang M
BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid level is correlated with the clinical, pathological progression and prognosis of IgA nephropathy: an observational retrospective pilot-study.
Lu P; Li X; Zhu N; Deng Y; Cai Y; Zhang T; Liu L; Lin X; Guo Y; Han M
PeerJ; 2020; 8():e10130. PubMed ID: 33194389
[TBL] [Abstract][Full Text] [Related]
12. The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.
Du Y; Chen S; Wang F; Zhang P; Liu M; Liu C; Zhong X; Qin J; Li G; Wang W
Front Med (Lausanne); 2022; 9():864667. PubMed ID: 35847826
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
Xiong L; Liu L; Tao Y; Guo H
J Nephrol; 2023 Nov; 36(8):2213-2222. PubMed ID: 37542609
[TBL] [Abstract][Full Text] [Related]
14. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
18. Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy.
Liu L; Duan A; Guo Q; Sun G; Cui W; Lu X; Yu H; Luo P
Exp Ther Med; 2021 Mar; 21(3):205. PubMed ID: 33500698
[TBL] [Abstract][Full Text] [Related]
19. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.
Hennino MF; Buob D; Van der Hauwaert C; Gnemmi V; Jomaa Z; Pottier N; Savary G; Drumez E; Noël C; Cauffiez C; Glowacki F
Sci Rep; 2016 Jun; 6():27209. PubMed ID: 27264483
[TBL] [Abstract][Full Text] [Related]
20. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
